John Paulson’s Paulson & Co. disclosed in an SEC filing its holdings as of September 30, 2023. The fund exited one position during the third quarter, namely Newmont (NEM). Pauslon increased its stake in two holdings, namely Horizon Therapeutics (HZNP) and Madrigal Pharma (MDGL). The fund’s top holdings as of September 30, in order of size, were Horizon Therapeutics, Bausch Health (BHC), Brightsphere Investment (BSIG), Novagold (NG), and Perpetua Resources (PPTA).
previous post